BAP1 and neoplasm: Similarly, the identification of atypical lesions, like BAP1-inactivated melanocytic tumors, requires nuanced clinical judgment and coordination with molecular diagnostics to guide patient management, even when the associated tumor type is not the presenting malignancy.